Exceptional response to pembrolizumab in a metastatic, chemotherapy/radiation resistant ovarian cancer patient harboring a CD274/PD-L1-genetic rearrangement.
| Author | |
|---|---|
| Abstract |
:
Ovarian carcinoma no longer responsive to surgery and chemotherapy remains an incurable disease. Alternative therapeutic options remain desperately needed. |
| Year of Publication |
:
2018
|
| Journal |
:
Clinical cancer research : an official journal of the American Association for Cancer Research
|
| Date Published |
:
2018
|
| ISSN Number |
:
1078-0432
|
| URL |
:
http://clincancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=29351920
|
| DOI |
:
10.1158/1078-0432.CCR-17-1805
|
| Short Title |
:
Clin Cancer Res
|
| Download citation |
